ArticleMicrobial biotechnology2018
Studies on the aerobic utilization of synthesis gas (syngas) by wild type and recombinant strains of Ralstonia eutropha H16.
Article in Microbial biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- The potential of syngas as a central mediator for a carbon-agnostic circular economy.Nature communications · 2026Review
- Cultivation ofBiotechnology reports (Amsterdam, Netherlands) · 2025Article
- Microbial synergy betweenGreen chemistry : an international journal and green chemistry resource : GC · 2025Article
- Synthetic biology toolkit of Ralstonia eutropha (Cupriavidus necator).Applied microbiology and biotechnology · 2024Review
- Strain and model development for auto- and heterotrophic 2,3-butanediol production using Cupriavidus necator H16.Biotechnology for biofuels and bioproducts · 2024Article
- Improving carbon monoxide tolerance ofFrontiers in bioengineering and biotechnology · 2023Article
- Industrial side streams as sustainable substrates for microbial production of poly(3-hydroxybutyrate) (PHB).World journal of microbiology & biotechnology · 2022Review
- Insights into the Degradation of Medium-Chain-Length Dicarboxylic Acids in Cupriavidus necator H16 Reveal β-Oxidation Differences between Dicarboxylic Acids and Fatty Acids.Applied and environmental microbiology · 2022Article
- Carbon Materials Advancing Microorganisms in Driving Soil Organic Carbon Regulation.Research (Washington, D.C.) · 2022Review
- Review
- Synthetic biology toolkit for engineering Cupriviadus necator H16 as a platform for COBiotechnology for biofuels · 2021Review
- Enhancement of biohydrogen production rate in Rhodospirillum rubrum by a dynamic CO-feeding strategy using dark fermentation.Biotechnology for biofuels · 2021Article
- Hydrogen oxidising bacteria for production of single-cell protein and other food and feed ingredients.Engineering biology · 2020Review
- Cell-Free Fermentation Broth ofFrontiers in microbiology · 2020Article
- The genetic basis of 3-hydroxypropanoate metabolism inBiotechnology for biofuels · 2019Article
- Efficient biochemical production of acetoin from carbon dioxide usingBiotechnology for biofuels · 2019Article
- Using gas mixtures of CO, COMicrobial biotechnology · 2018Review
- Studies on the aerobic utilization of synthesis gas (syngas) by wild type and recombinant strains of Ralstonia eutropha H16.Microbial biotechnology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The biotechnical platform strain Ralstonia eutropha H16 was genetically engineered to express a cox subcluster of the carboxydotrophic Oligotropha carboxidovoransOM5, including (i) the structural genes coxM, -S and -L, coding for an aerobic carbon monoxide dehydrogenase (CODH) and (ii) the genes coxD, -E, -F and -G, essential for the maturation of CODH. The cox
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.